Neurodegeneration is a condition in which the structure and/or function of neurons in the central nervous system (CNS) is impaired. Neurodegenerative diseases are the result of a gradual decline in neuronal function due to a number of complex causes, including genetic, physiological, and environmental factors. Neurodegenerative diseases are characterized by a progressive loss of motor and cognitive function, due to the breakdown of neurons in the brain and spinal cord. Common examples of neurodegenerative diseases include Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). Neurodegenerative diseases can be caused by a variety of factors, including genetic abnormalities, environmental insults such as head trauma, metabolic changes, or exposure to certain neurotoxins. The underlying mechanisms of these diseases remain unknown, and current research is focused on elucidating the neurodegenerative pathways involved. In many cases, scientists believe a combination of genetic and environmental factors play a role in the onset of neurodegenerative diseases. The symptoms of neurodegenerative diseases vary, but commonly include problems with memory, spatial orientation, language comprehension, and problem-solving abilities. In advanced stages, these cognitive problems can progress to include difficulty in writing, speaking, and even walking. While there is currently no cure for neurodegenerative diseases, treatments are available to help manage symptoms and slow the progression of the disease. The importance of ongoing research on neurodegeneration cannot be overstated. The better we understand the mechanisms of neurodegenerative diseases, the better we will be able to develop treatments or even find ways to prevent or delay the onset of these potentially devastating conditions.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States